Related Experiment Video
Updated: May 9, 2026

07:33
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
Published on: October 15, 2018
Enabling Automatic Generation of Protein-Ligand Complex Data Sets with Atomistic Detail.
Torben Gutermuth1, Emanuel S R Ehmki1, Florian Flachsenberg1
1University of Hamburg, ZBH─Center for Bioinformatics, Albert Einstein Ring 8-10, 22761 Hamburg, Germany.
Journal of Chemical Information and Modeling
|May 8, 2026
Summary
We developed StrAcTable, an automated method to create annotated protein-ligand complex datasets. This resource aids in developing structure-based drug design methods by providing high-quality data for machine learning model training.
Area of Science:
- Computational chemistry and cheminformatics
- Structural biology
- Drug discovery and development
Background:
- Predicting protein-ligand bioactivities is critical for drug discovery but challenging.
- Supervised machine learning models are competitive in structure-based drug design but require high-quality data.
- Integrating bioactivity and protein structure data from repositories like ChEMBL and PDB is difficult.
Purpose of the Study:
- To create an automated and continuously growing dataset of annotated protein-ligand complexes.
- To facilitate the development of structure-based molecular design methods.
- To provide a foundation for novel datasets for training and testing machine learning models.
Main Methods:
- Utilized ActivityFinder for automated linking of protein sequence/structure with bioactivity data.
- Integrated ActivityFinder with tools for structure quality estimation and property calculation.
- Constructed the StrAcTable dataset based on ChEMBL (Version 35) and PDB data.
Main Results:
- Created StrAcTable, an automatically generated dataset of 20,063 annotated protein-ligand complexes.
- StrAcTable includes detailed quality metrics for data matching, macromolecular structure, ligands, and bioactivity.
- The automated approach ensures sustainable growth and accessibility of the dataset.
Conclusions:
- StrAcTable offers a valuable resource for constructing training and validation datasets in structure-based drug design.
- The dataset supports the development and testing of both machine learning and traditional molecular design methods.
- Automated data generation is key for building comprehensive and up-to-date resources for computational drug discovery.

